Novavax Makes Big Move Donating 1.1 Billions Doses to Serum Institute of India as part of COVAX Deal
Novavax Inc. (Nasdaq: NVAX) inked a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance (Gavi), to supply up to […]
Volunteers Needed for Novavax Vaccine Trial at Womack Army Medical Center
Military and connected beneficiaries of Fort Bragg’s Military Health System and Tricare can lend a hand to help the biomedical […]
Rhode Island’s Lifespan Participates in Phase 3 Clinical Trial Evaluating Novavax COVID-19 Vaccine Candidate
Affiliated with Brown University, Rhode Island Hospitals and Health Services also known as Lifespan now seeks to enroll volunteers for […]
DOD-backed Novavax’s Vaccine Phase 3 Clinical Trial Comes to the Capital of the Intermountain West—Just in Time as Conditions Worsen
One of the first physician/investigators to distribute the Novavax vaccine in the recently launched Phase 3 clinical trial was showcased […]
UW Medicine Brings Innovative Approaches to Pivotal Phase 3 Novavax COVID-19 Vaccine Clinical Trial Including Mobile Sites
Led by Principal Investigator Dr. Scott McClelland and Dr. Anna Wald, the University of Washington School of Medicine (UW Medicine) […]
University of Iowa VTEU Initiates Phase 3 Novavax Clinical Trial Investigating COVID-19 Vaccine
The University of Iowa Health Care (UIHC) gains a more prominent role as a trial site hub investigating COVID-19 investigational […]
Novavax Announces COVID-19 Vaccine Clinical Development Progress
Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update on its […]
Small Tribe in Pacific Northwest Drop AZD1222 & Seek Participation in Novavax COVID-19 Vaccine Clinical Trial
What does a niche vaccine-focused biotech from Gaithersburg, MD toiling in relative obscurity for years and a small Native American […]
NHS Grampian via Aberdeen Royal Infirmary Seeks 450 Volunteers for NVX-CoV2373 COVID-19 Vaccine Phase 3 Trial in NE, Scotland
Back in August, the UK and American vaccine maker Novavax announced an agreement to proceed to a Phase 3 clinical […]
Novavax Taps into the $1.6b in U.S. Fed Award to Fund Phase 3 Clinical Trial in the UK in Pursuit of Euro Filing
Novavax Inc. (Nasdaq: NVAX) has progressed their investigational vaccine product for COVID-19 called NVX-CoV2373 to Phase 3 to evaluate the […]
